JP2019509329A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019509329A5 JP2019509329A5 JP2018556016A JP2018556016A JP2019509329A5 JP 2019509329 A5 JP2019509329 A5 JP 2019509329A5 JP 2018556016 A JP2018556016 A JP 2018556016A JP 2018556016 A JP2018556016 A JP 2018556016A JP 2019509329 A5 JP2019509329 A5 JP 2019509329A5
- Authority
- JP
- Japan
- Prior art keywords
- administered
- oncos
- adenovirus
- malignant mesothelioma
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021180012A JP2022023978A (ja) | 2016-01-15 | 2021-11-04 | がんを治療するためのアデノウイルス及び化学療法剤の組合せ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20165026 | 2016-01-15 | ||
| FI20165026A FI127460B (en) | 2016-01-15 | 2016-01-15 | Combining adenovirus and chemotherapeutic agents for treating cancer |
| PCT/FI2017/050010 WO2017121925A1 (en) | 2016-01-15 | 2017-01-11 | Combining adenovirus and chemotherapeutic agents for treating cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021180012A Division JP2022023978A (ja) | 2016-01-15 | 2021-11-04 | がんを治療するためのアデノウイルス及び化学療法剤の組合せ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019509329A JP2019509329A (ja) | 2019-04-04 |
| JP2019509329A5 true JP2019509329A5 (enExample) | 2020-02-20 |
| JP6974350B2 JP6974350B2 (ja) | 2021-12-01 |
Family
ID=57909646
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018556016A Expired - Fee Related JP6974350B2 (ja) | 2016-01-15 | 2017-01-11 | がんを治療するためのアデノウイルス及び化学療法剤の組合せ |
| JP2021180012A Pending JP2022023978A (ja) | 2016-01-15 | 2021-11-04 | がんを治療するためのアデノウイルス及び化学療法剤の組合せ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021180012A Pending JP2022023978A (ja) | 2016-01-15 | 2021-11-04 | がんを治療するためのアデノウイルス及び化学療法剤の組合せ |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190000898A1 (enExample) |
| EP (2) | EP3985120A1 (enExample) |
| JP (2) | JP6974350B2 (enExample) |
| CN (2) | CN108495934B (enExample) |
| ES (1) | ES2904611T3 (enExample) |
| FI (1) | FI127460B (enExample) |
| PL (1) | PL3402889T3 (enExample) |
| WO (1) | WO2017121925A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3610870A4 (en) * | 2017-03-31 | 2020-12-09 | Ogata, Hisanobu | METHOD OF EXPANSION OF AN ONCOLYTIC VIRUS AND ANTI-TUMOR AGENT |
| CA3074901A1 (en) | 2017-09-11 | 2019-03-14 | Imba - Institut Fur Molekulare Biotechnologie Gmbh | Tumor organoid model |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010006633A1 (en) | 1998-05-15 | 2001-07-05 | David Kirn | Adenovirus-chemotherapeutic combination for treating cancer |
| US6511676B1 (en) | 1999-11-05 | 2003-01-28 | Teni Boulikas | Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| SV2006002143A (es) * | 2004-06-16 | 2006-01-26 | Genentech Inc | Uso de un anticuerpo para el tratamiento del cancer resistente al platino |
| EP2197917A1 (en) * | 2007-09-28 | 2010-06-23 | Universitätsspital Basel | Immunoliposomes for treatment of cancer |
| WO2009044158A2 (en) * | 2007-10-03 | 2009-04-09 | Cancer Research Technology Limited | Inhibitors and uses |
| CN101411710B (zh) * | 2008-11-25 | 2011-06-15 | 江苏奥赛康药业有限公司 | 培美曲塞二钠冻干粉针剂及其制备方法 |
| ES2612889T3 (es) | 2008-12-22 | 2017-05-19 | Targovax Oy | Vectores adenovíricos oncolíticos y procedimientos y utilizaciones relacionados con los mismos |
| CA2865468C (en) * | 2011-03-11 | 2021-05-04 | Sarissa Inc. | Methods of treating cancer by inhibition of dna repair proteins |
| EP2806883B1 (en) * | 2012-01-25 | 2019-04-24 | DNAtrix, Inc. | Biomarkers and combination therapies using oncolytic virus and immunomodulation |
| SG10201913795TA (en) * | 2012-02-02 | 2020-03-30 | Univ Texas | Adenoviruses expressing heterologous tumor-associated antigens |
| DK2908865T3 (en) * | 2012-10-17 | 2019-01-28 | Vascular Biogenics Ltd | ADENOVIRUS THAT EXPRESSES A PHAS-CHIMARY AND ITS APPLICATION IN CANCER TREATMENT METHODS |
-
2016
- 2016-01-15 FI FI20165026A patent/FI127460B/en active
-
2017
- 2017-01-11 WO PCT/FI2017/050010 patent/WO2017121925A1/en not_active Ceased
- 2017-01-11 JP JP2018556016A patent/JP6974350B2/ja not_active Expired - Fee Related
- 2017-01-11 CN CN201780006703.7A patent/CN108495934B/zh not_active Expired - Fee Related
- 2017-01-11 EP EP21194362.6A patent/EP3985120A1/en not_active Withdrawn
- 2017-01-11 PL PL17701908T patent/PL3402889T3/pl unknown
- 2017-01-11 EP EP17701908.0A patent/EP3402889B1/en active Active
- 2017-01-11 US US16/067,991 patent/US20190000898A1/en not_active Abandoned
- 2017-01-11 ES ES17701908T patent/ES2904611T3/es active Active
- 2017-01-11 CN CN202111195743.5A patent/CN113694206A/zh active Pending
-
2021
- 2021-11-04 JP JP2021180012A patent/JP2022023978A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2964764T3 (es) | Combinación terapéutica que comprende un inhibidor de cdk y oxaliplatino | |
| JP2019206593A5 (enExample) | ||
| JP2020509024A5 (enExample) | ||
| JP2019536805A5 (enExample) | ||
| JP2012506448A5 (enExample) | ||
| JP2020523356A5 (enExample) | ||
| JP2014148535A5 (enExample) | ||
| JP2014513089A5 (enExample) | ||
| JP2014040437A5 (enExample) | ||
| NZ708506A (en) | Methods of treating bladder cancer | |
| JP2020523354A5 (enExample) | ||
| JP2015502926A5 (enExample) | ||
| HRP20171216T1 (hr) | Pripravak koji sadrži aflibercept, folinsku kiselinu, 5-fluorouracil (5-fu) i irinotekan (folfiri) | |
| JP2017506624A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2020523359A5 (enExample) | ||
| Gedlicka et al. | Phase II study with docetaxel and cisplatin in the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck | |
| JP2008514577A5 (enExample) | ||
| JP2017514854A5 (enExample) | ||
| BR112022019914A2 (pt) | Coadministração de mirdametinibe e lifirafenibe para uso no tratamento de cânceres | |
| WO2017182873A3 (en) | Peptide-oligourea foldamer compounds and methods of their use | |
| AR079174A1 (es) | Composiciones para comprimidos desintegrables oralmente de ondansetron para prevenir nauseas y vomitos | |
| RU2018107930A (ru) | Агонисты tlr4, их композиции и применение для лечения рака | |
| JP2019509329A5 (enExample) |